uspto-grants-2009_02 · 10.6084/m9.figshare.5104873.v1 · US07488825B2
查看IDENTITY
结构与身份
- 标准SMILES
- CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl
- InChIKey
- GURKHSYORGJETM-WAQYZQTGSA-N
- 分子式
- C33H39ClN4O6
- 平均分子量
- 623.1 g/mol
- 单同位素质量
- 622.2558127
COMPUTED
结构计算性质
- 极性表面积
- 113 Ų
- 氢键供体
- 2
- 氢键受体
- 8
- 可旋转键
- 5
- 重原子
- 44
- 形式电荷
- 0
- 复杂度
- 1,200
GHS
GHS分类
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 1 notifications to the ECHA C&L Inventory.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
HAZARDS
危害信息
Hazard Classes and Categories
Acute Tox. 4 (100%)
TOXICITY
毒理信息
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Irinotecan hydrochloride
vLess-DILI-concern
3
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
PHARMACOLOGY
药理信息
FDA Pharmacological Classification
IRINOTECAN HYDROCHLOIDE
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
IRINOTECAN HYDROCHLORIDE
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
MeSH Pharmacological Classification
Compounds that inhibit the activity of DNA TOPOISOMERASE I.
USES
用途与制造
Uses
Use (kg; approx.) in Germany (2009): >25;Use (kg) in USA (2002): 24;Consumption (g per capita; approx.) in Germany (2009): 0.000305;Consumption (g per capita) in the USA (2002): 8.51e-05;Calculated removal (%): 13.3
ALIASES
名称与别名
REACTIONS